Académique Documents
Professionnel Documents
Culture Documents
To cite this article: R. Sahana, S.C.G. Kiruba Daniel, S. Gowri Sankar, G. Archunan, S. John
Vennison & M. Sivakumar (2014) Formulation of bactericidal cold cream against clinical
pathogens using Cassia auriculata flower extract-synthesized Ag nanoparticles, Green
Chemistry Letters and Reviews, 7:1, 64-72, DOI: 10.1080/17518253.2014.895859
2014 The Author(s). Published by Taylor & Published online: 19 Mar 2014.
Francis.
RESEARCH ARTICLE
Formulation of bactericidal cold cream against clinical pathogens using Cassia auriculata
flower extract-synthesized Ag nanoparticles
R. Sahanaa, S.C.G. Kiruba Danielb, S. Gowri Sankarc, G. Archunana, S. John Vennisonc and M. Sivakumarb*
a
Department of Biotechnology and Genetic Engineering, Bharathidasan University, Tiruchirappalli, India; bDivision of
Nanoscience and Technology, Bharathidasan Institute of Technology, Anna University, Tiruchirappalli, India; cDepartment of
Biotechnology, Bharathidasan Institute of Technology, Anna University, Tiruchirappalli, India
A simple formulation of bactericidal cold cream using the biosynthesized silver nanoparticles (AgNPs) from
Cassia auriculata flower extract and their antibacterial activity was tested against various clinical pathogens such
as Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Staphylococcus epidermidis. An eco-
friendly method was followed for the biosynthesis of AgNPs using C. auriculata flower extract as a reducing agent
Downloaded by [117.221.239.164] at 03:27 14 July 2016
at room temperature. The effect of different concentrations of flower extract and the various pH conditions of the
reaction medium toward the formation of NPs were studied. Surface plasmon resonance peaks were obtained from
403 nm to 428 nm. Further, the synthesized NPs were characterized by dynamic light scattering particle size
analysis, Zeta potential analysis, atomic force microscope, and high-resolution transmission electron microscopic
analysis.
Keywords: biosynthesis; silver nanoparticles; Cassia auriculata; bactericidal cold cream; antibacterial activity
Figure 4. AFM (2D and 3D) image of C. auriculata ower extract-biosynthesized AgNPs exhibiting a size range of 2070 nm.
were autoclaved, dipped in the cream for 6 hours, and metallic NPs (22). Dhas et al. reported the synthesis of
placed over the bacteria-inoculated medium at 37C AgNPs from C. auriculata flower extract and evalu-
for 24 hours. The zone of inhibition was determined ated their antibacterial activities against bacterial
by measuring the diameter of the inhibition zone. strains such as Bacillus lichinifomis, Klebsiella planti-
cola. The syntheisized NPs showed a broad absorp-
tion spectrum which may be due to the presence of
3. Results and discussion NPs in a wide size range (23). We investigated the role
3.1. Synthesis of AgNPs of concentration of flower extract and pH of the
In recent years, many physical and chemical methods reaction medium toward the formation of AgNPs. We
have been adopted for the synthesis of NPs which have also formulated an bactericidal cold cream and
involve in the usage of organic surfactants and strong tested its efficiency against various clinical pathogens.
reducing agents like cetyl trimethylammonium brom- The reaction mixture containing the aqueous
ide (CTAB), sodium borohydride etc., thus the NPs solution of AgNO3 and flower extract starts to change
synthesized using toxic chemicals are not applicable the color from yellowish brown to reddish brown as
for the biological applications. This is because the shown in Figure 1, indicating the characteristic
surfactants cannot be completely removed from the optical properties of the AgNPs. Thus the plant
68 R. Sahana et al.
Downloaded by [117.221.239.164] at 03:27 14 July 2016
Figure 5. HRTEM images of AgNPs formed after the addition of C. auriculata ower extract shown at different scales of (a)
5 nm, (b) 50 nm, (c) 100 nm, and (d) SAED pattern.
phytochemicals such as terpenoids, tannin, flavo- depending on shape, size, and distribution of the NPs
noids, proteins, phenols, and saponin present in the (27). Further, the AgNPs have free electrons which
flower extract (24) play an important role in the give rise to SPR band, this is due to the combined
formation of NPs. So that once these phytochemicals vibrations of electrons of the metal NPs. Some of the
enter into the body along with the NPs, they do not important parameters such as temperature pH, dielec-
cause any harm. The possible mechanism involving in tric properties, shape, and size of the NPs influence
the reduction of AgNO3 ions is due to the formation the absorbance and position of the SPR band (28, 29).
of intermediate complexes with OH groups of phen- Thus the formation of AgNPs was confirmed using
olic compounds in the hydrolysable tannins, which
UV-spectral analysis. Figure 2 shows the UVvisible
undergoes oxidation to quinine forms resulting in the
spectra for AgNPs formed at different concentrations
reduction of Ag+ to AgNPs (25, 26).
of flower extract. From the graph, it was noticed that
the lowest amount of flower extract concentration
3.2. UVvisible spectral analysis was effective for the synthesis of AgNPs. The absor-
AgNPs exhibit unique, tunable optical properties on bance peak was centered between 422 nm and 427 nm
account of their surface plasmon resonance (SPR), which is the characteristic peak of AgNPs. Also the
Green Chemistry Letters and Reviews 69
Downloaded by [117.221.239.164] at 03:27 14 July 2016
Figure 6. (a) DLS (particle size analysis) of biosynthesized AgNPs. (b) Zeta potential analysis of biosynthesized AgNPs.
sharpness of the absorption peak is dependent on the The effect of pH on the formation of AgNPs was
concentration of flower extract, which gets further analyzed using UVvisible spectrophotometric stud-
sharpened at increase in the concentration of flower ies. From the results, it was found that the formation
extract this might be due to the narrow size of AgNPs was observed once the pH of the medium
distribution of the NPs. Thus the amount of flower reached pH 7 and the absorption peak was obtained
extract used for the synthesis of AgNPs was found to at 408.5 nm. At pH 9 and 11, the color intensity
be less when compared with the previous reports (30). increases from orange to reddish brown and the
Figure 7. Antimicrobial cream formulated, (A) control cream without the addition of AgNPs and (B) antimicrobial cream
formulated by adding 2 ml as synthesized bioAgNPs.
70 R. Sahana et al.
Downloaded by [117.221.239.164] at 03:27 14 July 2016
Figure 8. Antibacterial assays: zone of inhibition (mm) observed around the disks containing creams C control cream,
E extract containing cream, and BNPs bactericidal cream having AgNPs tested against (A) E. coli, (B) S. aureus, (C)
P. aeruginosa, and (D) S. epidermidis.
absorption peak was obtained at 404 nm and 403.5 reaction medium. The variation of color at different
nm, respectively (Figure 3). Thus the formation of pH condition is related to the difference in the
AgNPs occurs rapidly at the neutral pH and this dissociation constant (pKa) of various functional
might be due to the ionization of phenolic groups groups present in the flower extract that play an
present in the C. auriculata flower extract. At acidic important role in the reduction process (32).
condition of the reaction medium (pH3pH5), there
were no development of brown color or characteristic
peak of AgNPs. So that from the results it was 3.3. Analysis of particle size and topography
understood that the variety of biomolecules involved AFM studies showed that the AgNPs were similar in
in the formation of AgNPs are inactive under acidic shape and size, ranges between 20 nm and 70 nm. The
pH condition (31). Further, the slow rate of formation two-dimensional and three-dimensional view of the
and aggregation of NPs at the acidic pH might be due AgNPs was shown in Figure 4. HRTEM analysis was
to the electrostatic repulsion of anions present in the performed to analse the size and shape of the AgNPs.
Table 1. Zone of inhibition (mm) observed around the disks containing creams.
A E. coli 14 mm 7 mm
B S. aureus 12 mm
C P. aeruginosa 11 mm
D S. epidermidis 16 mm 9 mm
Green Chemistry Letters and Reviews 71
using Zeta potential measurement and it exhibited a and to bring the formulated bactericidal cold cream as
value of 9 mV (Figure 6b), which suggests that the
a cost-effective, patient-affordable cream in the mar-
AgNPs are highly stable and the large negative
ket against bacterial infections.
Zeta potential value might be due to the capping of
polphenolic constituents present in the flower extract
of C. auriculata (34). References
(1) Carlson, C.; Hussain, S.M.; Schrand, A.M.; Braydich,
L.K.; Hess, K.L.; Jones, R.L. J. Phys. Chem. B. 2008,
3.4. Antibacterial analysis of cold cream 112, 13608.
A bactericidal cold cream containing biosynthesized (2) Sharma, V.K.; Yngard, R.A.; Lin, Y. Adv. Colloid.
AgNPs using C. auriculata flower extract, and control Interf. Sci. 2009, 145, 83.
(3) Bar, H.; Bhui, D.K.; Sahoo, G.P.; Sarkar, P.; De, S.P.;
cream containing flower extract was formulated and it
Misra, A. Colloids Surf. A. Physicochem. Eng. Aspects.
is shown in Figure 7. Also their antibacterial effici- 2009, 339, 134.
ency was tested against the clinical isolates such as E. (4) Jae, Y.S.; Beom, S.K. Bioprocess Biosyst. Eng. 2009,
coli, P. aeruginosa, S. aureus, and S. epidermidis 32, 79.
through standard disk diffusion method. It was found (5) Sharma, V.K.; Yngard, R.A.; Lin, Y. Adv. Colloid
that the bactericidal cold cream exhibited an excellent Interf. Sci. 2009, 145, 83.
antibacterial activity against both Gram-positive and (6) Mohana, S.; Madhumitha, G.; Rahuman, A.A.;
Gram-negative organisms such as E. coli, P. aerugi- Kamaraj, C.; Bharathi, A.; Surendra, T.V. Ind. Crops
nosa, S. aureus, and S. epidermidis. The maximum Prod. 2013, 43, 631.
(7) Mukunthan, K.S.; Elumalai, E.K.; Patel, T.N.; Murty,
zone of inhibition for bactericidal cream was found to
V.R. Asian Pacific J. Trop. Biomed. 2011, 4, 270.
be 14 mm, 11 mm, 12 mm, and 16 mm which is
(8) Ahmad, N.; Sharma, S.; Alam, Md.K.; Singh, V.N.;
shown in Figure 8. The cold cream containing the Shamsi, S.F.; Mehta, B.R.; Fatma, A. Colloids Surf. B.
flower extract alone showed a minimum inhibitory Biointerf. 2010, 81, 81.
effect on the pathogens. But the bactericidal cold (9) Feng, Ql.; Wu, J.; Chen, G.Q.; Cui, F.Z.; Kim, T.N.;
cream containing the NPs synthesized from the flower Kim, J.O. J. Bio. Mat. Res. 2000, 52, 662.
extract showed an excellent antibacterial activity (10) Kora, A.J.; Arunacahalam, J. World J. Microbial.
shown in Table 1. This bactericidal activity is mainly Biotechnol. 2011, 27, 1209.
because of the release of silver cations from AgNPs (11) Huang, N.M.; Lim, H.N.; Radiman, S.; Khiew, P.S.;
which act as the reservoir for the Ag+ bactericidal Chiu, W.S.; Hashim, R.; Chia, C.H. Colloids Surf. A:
Physicochem. Eng. Aspects 2010, 353, 69.
agent. The interaction of the silver cations with the
(12) Nabikhan, A.; Kandasamy, K.; Raj, A.; Alikunhi, N.
cell membrane of bacteria leads to the increased M. Colloids Surf. B: Biointerf. 2010, 79, 488.
membrane permeability of the bacteria (35, 36). Kaviya (13) Shilaja Raj, M.; Roselin, P. Int. J. Pharm. Biosci. 2012,
et al. reported on the antibacterial activity of bio- 3, 0975.
synthesized AgNPs using Citrus sinensis peel extract (14) Rigo, C.; Ferroni, L.; Tocco, I.; Roman, M.; Muniv-
against E. coli, P. aeruginosa, and S. aureus (37). rana, I.; Gardin, C.; Cairns, W.R.L.; Vindigni, V.;
72 R. Sahana et al.
Azzena, B.; Barbante, C.; Zavan, B. Int. J. Mol. Sci. (27) Gopinath, V.; Mubarakali, D.; Priyadarshini, S.;
2013, 14, 4817. Priyadharsshini, N.M.; Thajuddin, N.; Velusamy, P.
(15) Gardea-Torresdey, J.L.; Gomez, E.; Peralta-Videa, J.; Colloids Surf. B: Biointerf. 2012, 96, 69.
Parsons, J.G.; Troiani, H.E.; Jose-Yacaman, M. (28) Suman, T.Y.; Rajasree, S.R.R.; Kanchana, A.;
Langmuir 2003, 19, 1357. Elizabeth, S.B. Colloids Surf. B.: Biointerf. 2013,
(16) Radha, N. Green Chem. Lett. Rev. 2012, 5, 707. 106, 74.
(17) Rani, P.U.; Rajasekharreddy, P.; Colloids Surf. A: (29) Kanmani, P.; Lim, S.T. Process Biochem. 2013,
Physicochem. Eng. Aspects 2011, 389, 188. 48, 1099.
(18) Subhadradevi, V.; Asokkumar, K.; Umamaheshwari, (30) Prabha, S.; Lahtinen, M.; Sillanp, M. Colloids Surf.
M.; Sivashanmugam, A.T.; Ushanandhini, J.R.; A: Physicochem. Eng. Aspects 2010, 364, 34.
Jaganathan, P. Bangladesh J. Sci. Ind. Res. 2011, (31) Daniel, S.C.G.K.; Nehru, K.; Sivakumar, M. Curr.
46, 513. Nanosci. 2012, 8, 125.
(19) Parveen, A.; Roy, A.S.; Rao, S. Int. J. Appl. Biol. (32) Bankar, A.; Joshi, B.; Ravi, A.; Zinjarde, S. Colloids
Pharm. Tech. 2012, 3, 976. Surf. A: Physicochem. Eng. Aspects 2010, 368, 58.
(20) Kiruba Daniel, S.C.G.; Nazeema Banu, B,; Harshiny, (33) Kumar, R.; Roopan, S.M.; Prabhakaran, A.; Khana,
M.; Nehru, K.; Sankar Ganesh, P.; Kumaran, S.; V.G.; Chakaroborty, S. Spectrochim. Acta Part A
Sivakumar, M. J. Exp. Nanosci. 2013, 1, 1. 2012, 90, 173.
(21) Baravakar, A.A.; Kale, R.N.; Patil, R.N.; Sawant, S. (34) Vivek, R.; Thangam, R.; Muthuchelian, K.;
D. Research J. Pharm. Tech. 2008, 4, 0974. Gunasekaran, P. Process Biochem. 2012, 47, 2405.
(22) Gupta, N.; Singh, H.P.; Sharma, R.K. Colloids Surf. (35) Yongqiang, Z.; Xinfeng, C.; Yuncang, Z.; Xinghua,
Downloaded by [117.221.239.164] at 03:27 14 July 2016
A: Physicochem. Eng. Aspects 2010, 367, 102. X.; Yunzhi, F. Colloids Surf. A: Physicochem. Eng.
(23) Dhas, G.; Jobitha, G.; Kannan, C.; Annadurai, G. Aspects 2013, 423, 63.
Drug Inven. Today 2012, 11, 579. (36) Mubarakali, D.; Thajuddin, N.; Jeganathan, K.;
(24) Priyadharshini, S.D.; Sujatha, V. Int. Res. J. Pharm. Gunasekaran, M. Colloids Surf. B: Biointerf. 2011,
2012, 2, 208. 85, 360.
(25) Dwivedi, A.D.; Gopal, K. Colloids Surf. A: Physico- (37) Kaviya, S.; Santhanalakshmi, J.; Viswanathan, B.;
chem. Eng. Aspects 2010, 369, 27. Muthumary, J.; Srinivasan, K. Spectrochim. Acta
(26) Kumar, A.; Chisti, Y.; Chand, U. Biotechnol. Adv. Part A 2011, 79, 594.
2013, 31, 346.